Zhang Yiheng, Yao Yajun
Department of Infectious Diseases and Hepatology, The Second Hospital of Shandong University, Jinan, China.
Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Road, Jinan, China.
Lipids Health Dis. 2025 Jan 24;24(1):20. doi: 10.1186/s12944-025-02442-8.
Obesity is linked to a variety of metabolic issues, with hyperlipidemia being a crucial adjustable risk element for cardiovascular diseases (CVD). However, the connection between indicators of obesity with overall and CVD mortality in American adults with hyperlipidemia remains unknown.
This research employed an extensive cohort drawn from the National Health and Nutrition Examination Survey (NHANES) (2003-2018). Hyperlipidemia was identified through either elevated lipid profiles or self-reported utilization of lipid-reducing medications. Obesity indicators (weight-adjusted waist index (WWI), waist-to-height ratio (WHtR), body mass index (BMI)) were evaluated by physical measurement data. Weighted Cox regression models and restricted cubic splines (RCS) were employed to assess the potential links between obesity indicators and mortality outcomes. Results were further validated through subgroup analyses to ensure robustness and reliability. The receiver operating characteristic (ROC) curve was utilized to evaluate the prognostic capability of obesity indicators for mortality.
This cohort study included data from 12,785 participants with hyperlipidemia. Over an average follow-up period of 8.4 years, a total of 1,454 deaths were documented, 380 of which were related to heart diseases. Cox analysis manifested that, after adjusting covariates, increased WWI was linked to a higher likelihood of overall and CVD mortality (both P < 0.05). RCS analysis illustrated that BMI and WHtR had U-shaped relationships with the overall and CVD mortality. Conversely, a linear positive association was uncovered between WWI and mortality (both P > 0.05 for nonlinearity). Age, alcohol consumption and chronic kidney disease had modifying effects on the relationship between WWI and total mortality among those with hyperlipidemia. The area under ROC indicated that WWI was more effective than for BMI and WHtR in predicting overall and CVD deaths.
In US adults with hyperlipidemia, the connection between BMI, WHtR, with overall and CVD mortality followed a U-shaped pattern, whereas a positive linear correlation was identified between WWI and mortality. WWI has superior predictive capability for the prognosis of individuals with hyperlipidemia compared to BMI and WHtR. These findings provide new insights and targets for the health management of individuals affected by hyperlipidemia.
肥胖与多种代谢问题相关,高脂血症是心血管疾病(CVD)的一个关键可调节风险因素。然而,在美国患有高脂血症的成年人中,肥胖指标与全因死亡率和心血管疾病死亡率之间的联系尚不清楚。
本研究采用了来自国家健康与营养检查调查(NHANES)(2003 - 2018年)的大量队列。通过血脂水平升高或自我报告使用降脂药物来确定高脂血症。肥胖指标(体重调整腰围指数(WWI)、腰高比(WHtR)、体重指数(BMI))通过体格测量数据进行评估。采用加权Cox回归模型和受限立方样条(RCS)来评估肥胖指标与死亡率结果之间的潜在联系。通过亚组分析进一步验证结果,以确保稳健性和可靠性。利用受试者工作特征(ROC)曲线来评估肥胖指标对死亡率的预后能力。
这项队列研究纳入了12785名高脂血症参与者的数据。在平均8.4年的随访期内,共记录了1454例死亡,其中380例与心脏病有关。Cox分析表明,在调整协变量后,WWI升高与全因死亡率和心血管疾病死亡率升高相关(P均<0.05)。RCS分析表明,BMI和WHtR与全因死亡率和心血管疾病死亡率呈U形关系。相反,发现WWI与死亡率呈线性正相关(非线性的P均>0.05)。年龄、饮酒和慢性肾病对高脂血症患者中WWI与总死亡率之间的关系有调节作用。ROC曲线下面积表明,在预测全因死亡和心血管疾病死亡方面,WWI比BMI和WHtR更有效。
在美国患有高脂血症的成年人中,BMI、WHtR与全因死亡率和心血管疾病死亡率之间的关系呈U形模式,而WWI与死亡率呈正线性相关。与BMI和WHtR相比,WWI对高脂血症患者的预后具有更好的预测能力。这些发现为高脂血症患者的健康管理提供了新的见解和靶点。